Your browser doesn't support javascript.
loading
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.
Phillip, Moshe; Nimri, Revital; Bergenstal, Richard M; Barnard-Kelly, Katharine; Danne, Thomas; Hovorka, Roman; Kovatchev, Boris P; Messer, Laurel H; Parkin, Christopher G; Ambler-Osborn, Louise; Amiel, Stephanie A; Bally, Lia; Beck, Roy W; Biester, Sarah; Biester, Torben; Blanchette, Julia E; Bosi, Emanuele; Boughton, Charlotte K; Breton, Marc D; Brown, Sue A; Buckingham, Bruce A; Cai, Albert; Carlson, Anders L; Castle, Jessica R; Choudhary, Pratik; Close, Kelly L; Cobelli, Claudio; Criego, Amy B; Davis, Elizabeth; de Beaufort, Carine; de Bock, Martin I; DeSalvo, Daniel J; DeVries, J Hans; Dovc, Klemen; Doyle, Francis J; Ekhlaspour, Laya; Shvalb, Naama Fisch; Forlenza, Gregory P; Gallen, Geraldine; Garg, Satish K; Gershenoff, Dana C; Gonder-Frederick, Linda A; Haidar, Ahmad; Hartnell, Sara; Heinemann, Lutz; Heller, Simon; Hirsch, Irl B; Hood, Korey K; Isaacs, Diana; Klonoff, David C.
Afiliación
  • Phillip M; The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 49202 Petah Tikva, Israel.
  • Nimri R; Sacker Faculty of Medicine, Tel-Aviv University, 39040 Tel-Aviv, Israel.
  • Bergenstal RM; The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 49202 Petah Tikva, Israel.
  • Barnard-Kelly K; Sacker Faculty of Medicine, Tel-Aviv University, 39040 Tel-Aviv, Israel.
  • Danne T; International Diabetes Center, HealthPartners Institute, Minneapolis, MN 55416, USA.
  • Hovorka R; Southern Health NHS Foundation Trust, Southampton, UK.
  • Kovatchev BP; AUF DER BULT, Diabetes-Center for Children and Adolescents, Endocrinology and General Paediatrics, Hannover, Germany.
  • Messer LH; Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Parkin CG; Center for Diabetes Technology, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
  • Ambler-Osborn L; Barbara Davis Center for Diabetes, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Amiel SA; CGParkin Communications, Inc., Henderson, NV, USA.
  • Bally L; Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
  • Beck RW; Department of Diabetes, King's College London, London, UK.
  • Biester S; Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital and University of Bern, Bern, Switzerland.
  • Biester T; Jaeb Center for Health Research Foundation, Inc., Tampa, FL 33647, USA.
  • Blanchette JE; AUF DER BULT, Diabetes-Center for Children and Adolescents, Endocrinology and General Paediatrics, Hannover, Germany.
  • Bosi E; AUF DER BULT, Diabetes-Center for Children and Adolescents, Endocrinology and General Paediatrics, Hannover, Germany.
  • Boughton CK; College of Nursing, University of Utah, Salt Lake City, UT 84112, USA.
  • Breton MD; Center for Diabetes and Obesity, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  • Brown SA; Diabetes Research Institute, IRCCS San Raffaele Hospital and San Raffaele Vita Salute University, Milan, Italy.
  • Buckingham BA; Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories, Cambridge, UK.
  • Cai A; Center for Diabetes Technology, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
  • Carlson AL; Center for Diabetes Technology, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
  • Castle JR; Division of Endocrinology, University of Virginia, Charlottesville, VA 22903, USA.
  • Choudhary P; Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, CA 94304, USA.
  • Close KL; The diaTribe Foundation/Close Concerns, San Diego, CA 94117, USA.
  • Cobelli C; International Diabetes Center, HealthPartners Institute, Minneapolis, MN 55416, USA.
  • Criego AB; Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR 97239, USA.
  • Davis E; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • de Beaufort C; The diaTribe Foundation/Close Concerns, San Diego, CA 94117, USA.
  • de Bock MI; Department of Woman and Child's Health, University of Padova, Padova, Italy.
  • DeSalvo DJ; International Diabetes Center, HealthPartners Institute, Minneapolis, MN 55416, USA.
  • DeVries JH; Telethon Kids Institute, University of Western Australia, Perth Children's Hospital, Perth, Australia.
  • Dovc K; Diabetes & Endocrine Care Clinique Pédiatrique DECCP/Centre Hospitalier Luxembourg, and Faculty of Sciences, Technology and Medicine, University of Luxembourg, Esch sur Alzette, GD Luxembourg/Department of Paediatrics, UZ-VUB, Brussels, Belgium.
  • Doyle FJ; Department of Paediatrics, University of Otago, Christchurch, New Zealand.
  • Ekhlaspour L; Division of Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77598, USA.
  • Shvalb NF; Amsterdam UMC, University of Amsterdam, Internal Medicine, Amsterdam, The Netherlands.
  • Forlenza GP; Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children's Hospital, Ljubljana, Slovenia, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Gallen G; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA.
  • Garg SK; Lucile Packard Children's Hospital-Pediatric Endocrinology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Gershenoff DC; The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 49202 Petah Tikva, Israel.
  • Gonder-Frederick LA; Barbara Davis Center for Diabetes, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Haidar A; Department of Diabetes, King's College London, London, UK.
  • Hartnell S; Barbara Davis Center for Diabetes, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Heinemann L; International Diabetes Center, HealthPartners Institute, Minneapolis, MN 55416, USA.
  • Heller S; Center for Diabetes Technology, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
  • Hirsch IB; Department of Biomedical Engineering, McGill University, Montreal, Canada.
  • Hood KK; Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Isaacs D; Science Consulting in Diabetes GmbH, Kaarst, Germany.
  • Klonoff DC; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Endocr Rev ; 44(2): 254-280, 2023 03 04.
Article en En | MEDLINE | ID: mdl-36066457
The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal glucose levels has been shown to prevent or delay the progression of the long-term complications of diabetes, a significant proportion of PwD are not attaining their glycemic goals. During the past 6 years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials and real-world studies have shown that the use of AID systems is safe and effective in helping PwD achieve their long-term glycemic goals while reducing hypoglycemia risk. Thus, AID systems have recently become an integral part of diabetes management. However, recommendations for using AID systems in clinical settings have been lacking. Such guided recommendations are critical for AID success and acceptance. All clinicians working with PwD need to become familiar with the available systems in order to eliminate disparities in diabetes quality of care. This report provides much-needed guidance for clinicians who are interested in utilizing AIDs and presents a comprehensive listing of the evidence payers should consider when determining eligibility criteria for AID insurance coverage.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Insulina Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Aspecto: Equity_inequality Límite: Humans Idioma: En Revista: Endocr Rev Año: 2023 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Insulina Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Aspecto: Equity_inequality Límite: Humans Idioma: En Revista: Endocr Rev Año: 2023 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos